Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashwini Joshi

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
BMJ Open|October 5, 2021
Ovarian Cancer Epidemiology, Healthcare Access and Disparities (ORCHiD): methodology for a population-based study of black, Hispanic and white patients with ovarian cancerTomi Akinyemiju, April Deveaux, Lauren Wilson, et al.
Scientific Reports|May 24, 2022
An inhibitor of RORγ for chronic pulmonary obstructive disease treatmentHarshada Desai, Megha Marathe, Varada Potdar, et al.
Breast Cancer Research and Treatment|June 1, 2026
Association of cumulative lifetime estrogen exposure and reproductive factors with breast cancer molecular subtype among Nigerian women in the MEND studyJovita Byemerwa, Drew Neish, Ebunoluwa Olunuga, et al.
Cancers|December 23, 2022
Development and Psychometric Evaluation of Healthcare Access Measures among Women with Ovarian CancerTomi Akinyemiju, Ashwini Joshi, April Deveaux, et al.
Breast Cancer Research and Treatment|July 10, 2026
Association of tumor-infiltrating lymphocytes and proinflammatory biomarkers with breast cancer molecular subtypes: analysis of the MEND studyJovita Byemerwa, Drew Neish, Lukeman Forgah, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
BMJ Open|October 5, 2021
Ovarian Cancer Epidemiology, Healthcare Access and Disparities (ORCHiD): methodology for a population-based study of black, Hispanic and white patients with ovarian cancerTomi Akinyemiju, April Deveaux, Lauren Wilson, et al.
Scientific Reports|May 24, 2022
An inhibitor of RORγ for chronic pulmonary obstructive disease treatmentHarshada Desai, Megha Marathe, Varada Potdar, et al.
Breast Cancer Research and Treatment|June 1, 2026
Association of cumulative lifetime estrogen exposure and reproductive factors with breast cancer molecular subtype among Nigerian women in the MEND studyJovita Byemerwa, Drew Neish, Ebunoluwa Olunuga, et al.
Cancers|December 23, 2022
Development and Psychometric Evaluation of Healthcare Access Measures among Women with Ovarian CancerTomi Akinyemiju, Ashwini Joshi, April Deveaux, et al.
Breast Cancer Research and Treatment|July 10, 2026
Association of tumor-infiltrating lymphocytes and proinflammatory biomarkers with breast cancer molecular subtypes: analysis of the MEND studyJovita Byemerwa, Drew Neish, Lukeman Forgah, et al.
Pageof 6